Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Newcells Biotech

Newcells Biotech
2014 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$7M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of a technology designed to produce induced pluripotent stem cells. The company's platform is at the forefront of the production and differentiation of human induced pluripotent stem cells (hiPSC), which is quickly advancing the field of pre-clinical disease modeling and drug safety evaluation, enabling researchers to research and test new drugs and screen potential drug molecules for efficacy and toxicity.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • Biomedicine West International Centre for Life
  • Times Square
  • Newcastle upon Tyne NE1 4EP
  • England, United Kingdom

+44 0191 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Newcells Biotech’s full profile, request a free trial.

Newcells Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC $7M 00.00 Completed Generating Revenue
3. Early Stage VC 04-Jul-2018 00.000 00.000 00.000 Completed Generating Revenue
2. Grant 10-Oct-2016 $239K Completed Generating Revenue
1. Seed Round 02-Sep-2015 $239K $239K 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Newcells Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
D2 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
D1 Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
C Ordinary 337,969 $0.000133 $1.96 $1.96 1x $1.96 11.67%
Ordinary A 29,500 $0.000133 $6.9 $6.9 1x $6.9 1.02%
To view this company’s complete Cap Table, request access »

Newcells Biotech Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DefiniGEN Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 0 00.000
000 0000000000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Gosselies, Belgium 00 000.00 0000000000 0 000.00
0000 00000000000 Private Equity-Backed Cambridgeshire, United Kingdom 00 00.000 0000000 0000 00.000
0000000 Formerly VC-backed Leuven, Belgium 00 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Newcells Biotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
NVM Private Equity PE/Buyout Minority 000 0000 000000 0
Northstar Ventures Venture Capital Minority 000 0000 000000 0

Newcells Biotech Executive Team (3)

Name Title Board
Seat
Contact
Info
Michael Nicholds Chief Executive Officer & Board Member
Lyle Armstrong Ph.D Board Member & Chief Scientific Officer
Majlinda Lako Ph.D Scientific Founder

Newcells Biotech Board Members (4)

Name Representing Role Since Contact
Info
Lyle Armstrong Ph.D Newcells Biotech Board Member & Chief Scientific Officer 000 0000
Michael Nicholds Newcells Biotech Chief Executive Officer & Board Member 000 0000
Sandy Primrose Self Non-Executive Chairman 000 0000
Timothy Levett NVM Private Equity Board Member 000 0000